|
1
|
GBD 2019 Blindness and Vision Impairment
Collaborators: Vision Loss Expert Group of the Global Burden of
Disease Study, . Causes of blindness and vision impairment in 2020
and trends over 30 years, and prevalence of avoidable blindness in
relation to VISION 2020: The right to sight: An analysis for the
global burden of disease study. Lancet Glob Health. 9:e144–e160.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tham YC, Li X, Wong TY, Quigley HA, Aung T
and Cheng CY: Global prevalence of glaucoma and projections of
glaucoma burden through 2040: A systematic review and
meta-analysis. Ophthalmology. 121:2081–2090. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kang JM and Tanna AP: Glaucoma. Med Clin
North Am. 105:493–510. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Quigley HA: Glaucoma. Lancet.
377:1367–1377. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Burgoyne CF, Downs JC, Bellezza AJ, Suh JK
and Hart RT: The optic nerve head as a biomechanical structure: A
new paradigm for understanding the role of IOP-related stress and
strain in the pathophysiology of glaucomatous optic nerve head
damage. Prog Retin Eye Res. 24:39–73. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weinreb RN, Aung T and Medeiros FA: The
pathophysiology and treatment of glaucoma: A review. JAMA.
311:1901–1911. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li L and Song F: Biomechanical research
into lamina cribrosa in glaucoma. Natl Sci Rev. 7:1277–1279. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Marcus MW, de Vries MM, Junoy Montolio FG
and Jansonius NM: Myopia as a risk factor for open-angle glaucoma:
A systematic review and meta-analysis. Ophthalmology.
118:1989–1994.e2. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ha A, Kim CY, Shim SR, Chang IB and Kim
YK: Degree of myopia and glaucoma risk: A dose-response
meta-analysis. Am J Ophthalmol. 236:107–119. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fong DS, Epstein DL and Allingham RR:
Glaucoma and myopia: Are they related? Int Ophthalmol Clin.
30:215–218. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Saw SM, Gazzard G, Shih-Yen EC and Chua
WH: Myopia and associated pathological complications. Ophthalmic
Physiol Opt. 25:381–391. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Juliano J, Burkemper B, Lee J, Nelson A,
LeTran V, Chu Z, Zhou G, Jiang X, Wang RK, Varma R and Richter GM:
Longer axial length potentiates relationship of intraocular
pressure and peripapillary vessel density in glaucoma patients.
Invest Ophthalmol Vis Sci. 62:372021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ren R, Wang N, Li B, Li L, Gao F, Xu X and
Jonas JB: Lamina cribrosa and peripapillary sclera histomorphometry
in normal and advanced glaucomatous Chinese eyes with various axial
length. Invest Ophthalmol Vis Sci. 50:2175–2184. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim KE and Park KH: Update on the
prevalence, etiology, diagnosis, and monitoring of normal-tension
glaucoma. Asia Pac J Ophthalmol (Phila). 5:23–31. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Killer HE and Pircher A: Normal tension
glaucoma: Review of current understanding and mechanisms of the
pathogenesis. Eye (Lond). 32:924–930. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mi XS, Yuan TF and So KF: The current
research status of normal tension glaucoma. Clin Interv Aging.
9:1563–1571. 2014.PubMed/NCBI
|
|
17
|
Chitranshi N, Rajput R, Godinez A,
Pushpitha K, Mirzaei M, Basavarajappa D, Gupta V, Sharma S, You Y,
Galliciotti G, et al: Neuroserpin gene therapy inhibits retinal
ganglion cell apoptosis and promotes functional preservation in
glaucoma. Mol Ther. 31:2056–2076. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miglior S, Torri V, Zeyen T, Pfeiffer N,
Vaz JC and Adamsons I; EGPS Group, : Intercurrent factors
associated with the development of open-angle glaucoma in the
European glaucoma prevention study. Am J Ophthalmol. 144:266–275.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Suzuki Y, Iwase A, Araie M, Yamamoto T,
Abe H, Shirato S, Kuwayama Y, Mishima HK, Shimizu H, Tomita G, et
al: Risk factors for open-angle glaucoma in a Japanese population:
The Tajimi study. Ophthalmology. 113:1613–1617. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Saccà SC and Izzotti A: Oxidative stress
and glaucoma: Injury in the anterior segment of the eye. Prog Brain
Res. 173:385–407. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Flammer J and Mozaffarieh M: What is the
present pathogenetic concept of glaucomatous optic neuropathy? Surv
Ophthalmol. 52 (Suppl 2):S162–S173. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shen WC, Huang BQ and Yang J: Regulatory
mechanisms of retinal ganglion cell death in normal tension
glaucoma and potential therapies. Neural Regen Res. 18:87–93. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kerr JF, Wyllie AH and Currie AR:
Apoptosis: A basic biological phenomenon with wide-ranging
implications in tissue kinetics. Br J Cancer. 26:239–257. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fleisher TA: Apoptosis. Ann Allergy Asthma
Immunol. 78:245–250. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li C, Liu W, Wang F, Hayashi T, Mizuno K,
Hattori S, Fujisaki H and Ikejima T: DNA damage-triggered
activation of cGAS-STING pathway induces apoptosis in human
keratinocyte HaCaT cells. Mol Immunol. 131:180–190. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu J, Sun W, Song Y, Liu J, Xue F, Gong K,
Yang X and Kang Q: SIRT6 protects retinal ganglion cells against
hydrogen peroxide-induced apoptosis and oxidative stress by
promoting Nrf2/ARE signaling via inhibition of Bach1. Chem Biol
Interact. 300:151–158. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Y, Osakue D, Yang E, Zhou Y, Gong H,
Xia X and Du Y: Endoplasmic reticulum stress response of trabecular
meshwork stem cells and trabecular meshwork cells and protective
effects of activated PERK pathway. Invest Ophthalmol Vis Sci.
60:265–273. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang M, Tan J, Miao Y, Li M and Zhang Q:
Role of Ca2+ and ion channels in the regulation of
apoptosis under hypoxia. Histol Histopathol. 33:237–246.
2018.PubMed/NCBI
|
|
30
|
Liu Z, Fu G and Liu A: The relationship
between inflammatory mediator expression in the aqueous humor and
secondary glaucoma incidence after silicone oil tamponade. Exp Ther
Med. 14:5833–5836. 2017.PubMed/NCBI
|
|
31
|
Saraste A and Pulkki K: Morphologic and
biochemical hallmarks of apoptosis. Cardiovasc Res. 45:528–537.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Geske FJ and Gerschenson LE: The biology
of apoptosis. Hum Pathol. 32:1029–1038. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Baleriola J, García-Feijoo J,
Martínez-de-la-Casa JM, Fernández-Cruz A, de la Rosa EJ and
Fernández-Durango R: Apoptosis in the trabecular meshwork of
glaucomatous patients. Mol Vis. 14:1513–1516. 2008.PubMed/NCBI
|
|
34
|
Galvao J, Davis BM and Cordeiro MF: In
vivo imaging of retinal ganglion cell apoptosis. Curr Opin
Pharmacol. 13:123–127. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Krishnan A, Kocab AJ, Zacks DN,
Marshak-Rothstein A and Gregory-Ksander M: A small peptide
antagonist of the Fas receptor inhibits neuroinflammation and
prevents axon degeneration and retinal ganglion cell death in an
inducible mouse model of glaucoma. J Neuroinflammation. 16:1842019.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen X, Lei F, Zhou C, Chodosh J, Wang L,
Huang Y, Dohlman CH and Paschalis EI: Glaucoma after ocular surgery
or trauma: The role of infiltrating monocytes and their response to
cytokine inhibitors. Am J Pathol. 190:2056–2066. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dohlman CH, Zhou C, Lei F, Cade F,
Regatieri CV, Črnej A, Dohlman JG, Shen LQ and Paschalis EI:
Glaucoma after corneal trauma or surgery-A rapid, inflammatory,
IOP-independent pathway. Cornea. 38:1589–1594. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rasmussen CA, Kaufman PL and Kiland JA:
Benzalkonium chloride and glaucoma. J Ocul Pharmacol Ther.
30:163–169. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Almasieh M, Wilson AM, Morquette B, Cueva
Vargas JL and Di Polo A: The molecular basis of retinal ganglion
cell death in glaucoma. Prog Retin Eye Res. 31:152–181. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu A, Khawaja AP, Pasquale LR and Stein
JD: A review of systemic medications that may modulate the risk of
glaucoma. Eye (Lond). 34:12–28. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hamard P, Blondin C, Debbasch C, Warnet
JM, Baudouin C and Brignole F: In vitro effects of preserved and
unpreserved antiglaucoma drugs on apoptotic marker expression by
human trabecular cells. Graefes Arch Clin Exp Ophthalmol.
241:1037–1043. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gedde SJ, Schiffman JC, Feuer WJ, Herndon
LW, Brandt JD and Budenz DL; Tube versus Trabeculectomy Study
Group, : Treatment outcomes in the tube versus trabeculectomy (TVT)
study after five years of follow-up. Am J Ophthalmol.
153:789–803.e2. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Javaid U, Ali MH, Jamal S and Butt NH:
Pathophysiology, diagnosis, and management of glaucoma associated
with Sturge-Weber syndrome. Int Ophthalmol. 38:409–416.
2018.PubMed/NCBI
|
|
44
|
Yoon PS and Singh K: Update on
antifibrotic use in glaucoma surgery, including use in
trabeculectomy and glaucoma drainage implants and combined cataract
and glaucoma surgery. Curr Opin Ophthalmol. 15:141–146. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Paschalis EI, Lei F, Zhou C, Chen XN,
Kapoulea V, Hui PC, Dana R, Chodosh J, Vavvas DG and Dohlman CH:
Microglia regulate neuroglia remodeling in various ocular and
retinal injuries. J Immunol. 202:539–549. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cade F, Paschalis EI, Regatieri CV, Vavvas
DG, Dana R and Dohlman CH: Alkali burn to the eye: Protection using
TNF-α inhibition. Cornea. 33:382–389. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ju KR, Kim HS, Kim JH, Lee NY and Park CK:
Retinal glial cell responses and Fas/FasL activation in rats with
chronic ocular hypertension. Brain Res. 1122:209–221. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Quigley HA, Nickells RW, Kerrigan LA,
Pease ME, Thibault DJ and Zack DJ: Retinal ganglion cell death in
experimental glaucoma and after axotomy occurs by apoptosis. Invest
Ophthalmol Vis Sci. 36:774–786. 1995.PubMed/NCBI
|
|
49
|
Libby RT, Li Y, Savinova OV, Barter J,
Smith RS, Nickells RW and John SW: Susceptibility to
neurodegeneration in a glaucoma is modified by Bax gene dosage.
PLoS Genet. 1:17–26. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kerrigan LA, Zack DJ, Quigley HA, Smith SD
and Pease ME: TUNEL-positive ganglion cells in human primary
open-angle glaucoma. Arch Ophthalmol. 115:1031–1035. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Tök L, Nazıroğlu M, Uğuz AC and Tök O:
Elevated hydrostatic pressures induce apoptosis and oxidative
stress through mitochondrial membrane depolarization in PC12
neuronal cells: A cell culture model of glaucomaz: A cell culture
model of glaucoma. J Recept Signal Transduct Res. 34:410–416. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Erisgin Z, Ozer MA, Tosun M, Ozen S and
Takir S: The effects of intravitreal H2 S application on
apoptosis in the retina and cornea in experimental glaucoma model.
Int J Exp Pathol. 100:330–336. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ying Y, Xue R, Yang Y, Zhang SX, Xiao H,
Zhu H, Li J, Chen G, Ye Y, Yu M, et al: Activation of ATF4 triggers
trabecular meshwork cell dysfunction and apoptosis in POAG. Aging
(Albany NY). 13:8628–8642. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Saccà SC, Pulliero A and Izzotti A: The
dysfunction of the trabecular meshwork during glaucoma course. J
Cell Physiol. 230:510–525. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Saccà SC, Gandolfi S, Bagnis A, Manni G,
Damonte G, Traverso CE and Izzotti A: From DNA damage to functional
changes of the trabecular meshwork in aging and glaucoma. Ageing
Res Rev. 29:26–41. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ammar DA and Kahook MY: Effects of
benzalkonium chloride- or polyquad-preserved fixed combination
glaucoma medications on human trabecular meshwork cells. Mol Vis.
17:1806–1813. 2011.PubMed/NCBI
|
|
57
|
Goldstein MH, Silva FQ, Blender N, Tran T
and Vantipalli S: Ocular benzalkonium chloride exposure: Problems
and solutions. Eye (Lond). 36:361–368. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Baudouin C, Kolko M, Melik-Parsadaniantz S
and Messmer EM: Inflammation in glaucoma: From the back to the
front of the eye, and beyond. Prog Retin Eye Res. 83:1009162021.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Liton PB and Gonzalez P: Stress response
of the trabecular meshwork. J Glaucoma. 17:378–385. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Rohen JW, Lütjen-Drecoll E, Flügel C,
Meyer M and Grierson I: Ultrastructure of the trabecular meshwork
in untreated cases of primary open-angle glaucoma (POAG). Exp Eye
Res. 56:683–692. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Stamer WD and Acott TS: Current
understanding of conventional outflow dysfunction in glaucoma. Curr
Opin Ophthalmol. 23:135–143. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Yan X, Wu S, Liu Q, Li Y, Zhu W and Zhang
J: Accumulation of Asn450Tyr mutant myocilin in ER promotes
apoptosis of human trabecular meshwork cells. Mol Vis. 26:563–573.
2020.PubMed/NCBI
|
|
63
|
Agarwal R, Talati M, Lambert W, Clark AF,
Wilson SE, Agarwal N and Wordinger RJ: Fas-activated apoptosis and
apoptosis mediators in human trabecular meshwork cells. Exp Eye
Res. 68:583–590. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Suri F, Yazdani S and Elahi E: LTBP2
knockdown and oxidative stress affect glaucoma features including
TGFβ pathways, ECM genes expression and apoptosis in trabecular
meshwork cells. Gene. 673:70–81. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Oritani K, Aoyama K, Tomiyama Y, Kincade
PW and Matsuzawa Y: Stromal cell CD9 and the differentiation of
hematopoietic stem/progenitor cells. Leuk Lymphoma. 38:147–152.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Jiang X, Teng M, Ji R, Zhang D, Zhang Z,
Lv Y, Zhang Q, Zhang J and Huang Y: CD9 regulates keratinocyte
differentiation and motility by recruiting E-cadherin to the plasma
membrane and activating the PI3K/Akt pathway. Biochim Biophys Acta
Mol Cell Res. 1867:1185742020. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Yan J, Yang X, Jiao X, Yang X, Guo M, Chen
Y, Zhan L and Chen W: Integrative transcriptomic and proteomic
analysis reveals CD9/ITGA4/PI3K-Akt axis mediates trabecular
meshwork cell apoptosis in human glaucoma. J Cell Mol Med.
24:814–829. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Wang Y, Li F and Wang S: MicroRNA-93 is
overexpressed and induces apoptosis in glaucoma trabecular meshwork
cells. Mol Med Rep. 14:5746–5750. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Shen Y, Zhu Y and Rong F: miR-200c-3p
regulates the proliferation and apoptosis of human trabecular
meshwork cells by targeting PTEN. Mol Med Rep. 22:1605–1612. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Wang X, Li Z, Bai J, Song W and Zhang F:
miR-17-5p regulates the proliferation and apoptosis of human
trabecular meshwork cells by targeting phosphatase and tensin
homolog. Mol Med Rep. 19:3132–3138. 2019.PubMed/NCBI
|
|
71
|
Wang Y, Zhou H, Liu X, Han Y, Pan S and
Wang Y: MiR-181a inhibits human trabecular meshwork cell apoptosis
induced by H2O2 through the suppression of
NF-κB and JNK pathways. Adv Clin Exp Med. 27:577–582. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Wang K, Read AT, Sulchek T and Ethier CR:
Trabecular meshwork stiffness in glaucoma. Exp Eye Res. 158:3–12.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Fuchshofer R and Tamm ER: The role of
TGF-β in the pathogenesis of primary open-angle glaucoma. Cell
Tissue Res. 347:279–290. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Wang J, Liu X and Zhong Y:
Rho/Rho-associated kinase pathway in glaucoma (review). Int J
Oncol. 43:1357–1367. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Vernazza S, Tirendi S, Passalacqua M,
Piacente F, Scarfì S, Oddone F and Bassi AM: An innovative in vitro
open-angle glaucoma model (IVOM) shows changes induced by increased
ocular pressure and oxidative stress. Int J Mol Sci. 22:121292021.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Soto I and Howell GR: The complex role of
neuroinflammation in glaucoma. Cold Spring Harb Perspect Med.
4:a0172692014. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Ebneter A, Casson RJ, Wood JP and Chidlow
G: Microglial activation in the visual pathway in experimental
glaucoma: Spatiotemporal characterization and correlation with
axonal injury. Invest Ophthalmol Vis Sci. 51:6448–6460. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Bordone MP, González Fleitas MF, Pasquini
LA, Bosco A, Sande PH, Rosenstein RE and Dorfman D: Involvement of
microglia in early axoglial alterations of the optic nerve induced
by experimental glaucoma. J Neurochem. 142:323–337. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Guo L, Moss SE, Alexander RA, Ali RR,
Fitzke FW and Cordeiro MF: Retinal ganglion cell apoptosis in
glaucoma is related to intraocular pressure and IOP-induced effects
on extracellular matrix. Invest Ophthalmol Vis Sci. 46:175–182.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Bosco A, Steele MR and Vetter ML: Early
microglia activation in a mouse model of chronic glaucoma. J Comp
Neurol. 519:599–620. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Bosco A, Romero CO, Breen KT, Chagovetz
AA, Steele MR, Ambati BK and Vetter ML: Neurodegeneration severity
can be predicted from early microglia alterations monitored in vivo
in a mouse model of chronic glaucoma. Dis Model Mech. 8:443–455.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Williams PA, Marsh-Armstrong N and Howell
GR; Lasker/IRRF Initiative on Astrocytes and Glaucomatous
Neurodegeneration Participants, : Neuroinflammation in glaucoma: A
new opportunity. Exp Eye Res. 157:20–27. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Tribble JR, Kokkali E, Otmani A, Plastino
F, Lardner E, Vohra R, Kolko M, André H, Morgan JE and Williams PA:
When is a control not a control? Reactive microglia occur
throughout the control contralateral pathway of retinal ganglion
cell projections in experimental glaucoma. Transl Vis Sci Technol.
10:222021. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Unlu M, Aktas Z, Gocun PU, Ilhan SO,
Hasanreisoglu M and Hasanreisoglu B: Neuroprotective effect of
systemic and/or intravitreal rosuvastatin administration in rat
glaucoma model. Int J Ophthalmol. 9:340–347. 2016.PubMed/NCBI
|
|
85
|
Dyka FM, May CA and Enz R: Metabotropic
glutamate receptors are differentially regulated under elevated
intraocular pressure. J Neurochem. 90:190–202. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Wu X, Dou YN, Fei Z and Fei F: Parkin
prevents glutamate excitotoxicity through inhibiting NLRP3
inflammasome in retinal ganglion cells. Neuroscience. 478:1–10.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Murphy G, Knäuper V, Lee MH, Amour A,
Worley JR, Hutton M, Atkinson S, Rapti M and Williamson R: Role of
TIMPs (tissue inhibitors of metalloproteinases) in pericellular
proteolysis: The specificity is in the detail. Biochem Soc Symp.
65–80. 2003.PubMed/NCBI
|
|
88
|
Mathew DJ, Livne-Bar I and Sivak JM: An
inducible rodent glaucoma model that exhibits gradual sustained
increase in intraocular pressure with distinct inner retina and
optic nerve inflammation. Sci Rep. 11:228802021. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Sakata R, Ueno T, Nakamura T, Ueno H and
Sata M: Mechanical stretch induces TGF-beta synthesis in hepatic
stellate cells. Eur J Clin Invest. 34:129–136. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Kirwan RP, Crean JK, Fenerty CH, Clark AF
and O'Brien CJ: Effect of cyclical mechanical stretch and exogenous
transforming growth factor-beta1 on matrix metalloproteinase-2
activity in lamina cribrosa cells from the human optic nerve head.
J Glaucoma. 13:327–334. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Gomes LR, Terra LF, Wailemann RA, Labriola
L and Sogayar MC: TGF-β1 modulates the homeostasis between MMPs and
MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive
breast cancer cells. BMC Cancer. 12:262012. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Cordeiro MF, Bhattacharya SS, Schultz GS
and Khaw PT: TGF-beta1, -beta2, and -beta3 in vitro: Biphasic
effects on Tenon's fibroblast contraction, proliferation, and
migration. Invest Ophthalmol Vis Sci. 41:756–763. 2000.PubMed/NCBI
|
|
93
|
Nguyen TTM, Gillet G and Popgeorgiev N:
Caspases in the developing central nervous system: Apoptosis and
beyond. Front Cell Dev Biol. 9:7024042021. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Cohen GM: Caspases: The executioners of
apoptosis. Biochem J. 326:1–16. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Abate M, Festa A, Falco M, Lombardi A,
Luce A, Grimaldi A, Zappavigna S, Sperlongano P, Irace C, Caraglia
M and Misso G: Mitochondria as playmakers of apoptosis, autophagy
and senescence. Semin Cell Dev Biol. 98:139–153. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Alapati T, Sagal KM, Gudiseva HV, Pistilli
M, Pyfer M, Chavali VRM and O'Brien JM: Evaluating TNF-α and
interleukin-2 (IL-2) levels in African American primary open-angle
glaucoma patients. Genes (Basel). 13:542021. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Wilson NS, Dixit V and Ashkenazi A: Death
receptor signal transducers: Nodes of coordination in immune
signaling networks. Nat Immunol. 10:348–355. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Mahdizadeh SJ, Thomas M and Eriksson LA:
Reconstruction of the Fas-based death-inducing signaling complex
(DISC) using a protein-protein docking meta-approach. J Chem Inf
Model. 61:3543–3558. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Hillert-Richter LK and Lavrik IN:
Measuring composition of CD95 death-inducing signaling complex and
processing of procaspase-8 in this complex. J Vis Exp. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Yang XJ, Ge J and Zhuo YH: Role of
mitochondria in the pathogenesis and treatment of glaucoma. Chin
Med J (Engl). 126:4358–4365. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Zeng Z, You M, Fan C, Rong R, Li H and Xia
X: Pathologically high intraocular pressure induces mitochondrial
dysfunction through Drp1 and leads to retinal ganglion cell
PANoptosis in glaucoma. Redox Biol. 62:1026872023. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Bock FJ and Tait SWG: Mitochondria as
multifaceted regulators of cell death. Nat Rev Mol Cell Biol.
21:85–100. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Saelens X, Festjens N, Vande Walle L, van
Gurp M, van Loo G and Vandenabeele P: Toxic proteins released from
mitochondria in cell death. Oncogene. 23:2861–2874. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Shakeri R, Kheirollahi A and Davoodi J:
Apaf-1: Regulation and function in cell death. Biochimie.
135:111–125. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Brentnall M, Rodriguez-Menocal L, De
Guevara RL, Cepero E and Boise LH: Caspase-9, caspase-3 and
caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell
Biol. 14:322013. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Kale J, Osterlund EJ and Andrews DW: BCL-2
family proteins: Changing partners in the dance towards death. Cell
Death Differ. 25:65–80. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Leibowitz B and Yu J: Mitochondrial
signaling in cell death via the Bcl-2 family. Cancer Biol Ther.
9:417–422. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Ding J, Mooers BHM, Zhang Z, Kale J,
Falcone D, McNichol J, Huang B, Zhang XC, Xing C, Andrews DW and
Lin J: After embedding in membranes antiapoptotic Bcl-XL protein
binds both Bcl-2 homology region 3 and helix 1 of proapoptotic Bax
protein to inhibit apoptotic mitochondrial permeabilization. J Biol
Chem. 289:11873–11896. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Luna-Vargas MPA and Chipuk JE: The deadly
landscape of pro-apoptotic BCL-2 proteins in the outer
mitochondrial membrane. FEBS J. 283:2676–2689. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Huang DC and Strasser A: BH3-Only
proteins-essential initiators of apoptotic cell death. Cell.
103:839–842. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Bano D and Prehn JHM: Apoptosis-inducing
factor (AIF) in physiology and disease: The tale of a repented
natural born killer. EBioMedicine. 30:29–37. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Porat S and Simantov R: Bcl-2 and p53:
Role in dopamine-induced apoptosis and differentiation. Ann N Y
Acad Sci. 893:372–375. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Sawada O, Perusek L, Kohno H, Howell SJ,
Maeda A, Matsuyama S and Maeda T: All-trans-retinal induces Bax
activation via DNA damage to mediate retinal cell apoptosis. Exp
Eye Res. 123:27–36. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Wang Y, Okan I, Szekely L, Klein G and
Wiman KG: bcl-2 inhibits wild-type p53-triggered apoptosis but not
G1 cell cycle arrest and transactivation of WAF1 and bax. Cell
Growth Differ. 6:1071–1075. 1995.PubMed/NCBI
|
|
115
|
Chylicki K, Ehinger M, Svedberg H and
Gullberg U: Characterization of the molecular mechanisms for
p53-mediated differentiation. Cell Growth Differ. 11:561–571.
2000.PubMed/NCBI
|
|
116
|
Oakes SA and Papa FR: The role of
endoplasmic reticulum stress in human pathology. Annu Rev Pathol.
10:173–194. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Hetz C, Zhang K and Kaufman RJ:
Mechanisms, regulation and functions of the unfolded protein
response. Nat Rev Mol Cell Biol. 21:421–438. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Ron D and Walter P: Signal integration in
the endoplasmic reticulum unfolded protein response. Nat Rev Mol
Cell Biol. 8:519–529. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Lafleur MA, Stevens JL and Lawrence JW:
Xenobiotic perturbation of ER stress and the unfolded protein
response. Toxicol Pathol. 41:235–262. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Urano F, Wang X, Bertolotti A, Zhang Y,
Chung P, Harding HP and Ron D: Coupling of stress in the ER to
activation of JNK protein kinases by transmembrane protein kinase
IRE1. Science. 287:664–666. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Kwong JMK and Caprioli J: Expression of
phosphorylated c-Jun N-terminal protein kinase (JNK) in
experimental glaucoma in rats. Exp Eye Res. 82:576–582. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Hwang J and Qi L: Quality control in the
endoplasmic reticulum: Crosstalk between ERAD and UPR pathways.
Trends Biochem Sci. 43:593–605. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Maurel M, Chevet E, Tavernier J and Gerlo
S: Getting RIDD of RNA: IRE1 in cell fate regulation. Trends
Biochem Sci. 39:245–254. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Hayashi T, Saito A, Okuno S, Ferrand-Drake
M, Dodd RL and Chan PH: Oxidative injury to the endoplasmic
reticulum in mouse brains after transient focal ischemia. Neurobiol
Dis. 15:229–239. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Wek RC, Jiang HY and Anthony TG: Coping
with stress: eIF2 kinases and translational control. Biochem Soc
Trans. 34:7–11. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Peters JC, Bhattacharya S, Clark AF and
Zode GS: Increased endoplasmic reticulum stress in human
glaucomatous trabecular meshwork cells and tissues. Invest
Ophthalmol Vis Sci. 56:3860–3868. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Marola OJ, Syc-Mazurek SB and Libby RT:
DDIT3 (CHOP) contributes to retinal ganglion cell somal loss but
not axonal degeneration in DBA/2J mice. Cell Death Discov.
5:1402019. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Kasetti RB, Patel PD, Maddineni P, Patil
S, Kiehlbauch C, Millar JC, Searby CC, Raghunathan V, Sheffield VC
and Zode GS: ATF4 leads to glaucoma by promoting protein synthesis
and ER client protein load. Nat Commun. 11:55942020. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Doh SH, Kim JH, Lee KM, Park HY and Park
CK: Retinal ganglion cell death induced by endoplasmic reticulum
stress in a chronic glaucoma model. Brain Res. 1308:158–166. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Yoshida H, Matsui T, Yamamoto A, Okada T
and Mori K: XBP1 mRNA is induced by ATF6 and spliced by IRE1 in
response to ER stress to produce a highly active transcription
factor. Cell. 107:881–891. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Watanabe M, Ida Y, Furuhashi M, Tsugeno Y,
Ohguro H and Hikage F: Screening of the drug-induced effects of
prostaglandin EP2 and FP agonists on 3D cultures of
dexamethasone-treated human trabecular meshwork cells.
Biomedicines. 9:9302021. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Lee EJ, Chan P, Chea L, Kim K, Kaufman RJ
and Lin JH: ATF6 is required for efficient rhodopsin clearance and
retinal homeostasis in the P23H rho retinitis pigmentosa mouse
model. Sci Rep. 11:163562021. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Julien O and Wells JA: Caspases and their
substrates. Cell Death Differ. 24:1380–1389. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Yuan J, Shaham S, Ledoux S, Ellis HM and
Horvitz HR: The C. elegans cell death gene ced-3 encodes a protein
similar to mammalian interleukin-1 beta-converting enzyme. Cell.
75:641–652. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Van Opdenbosch N and Lamkanfi M: Caspases
in cell death, inflammation, and disease. Immunity. 50:1352–1364.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Ramirez MLG and Salvesen GS: A primer on
caspase mechanisms. Semin Cell Dev Biol. 82:79–85. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Man SM, Karki R and Kanneganti TD:
Molecular mechanisms and functions of pyroptosis, inflammatory
caspases and inflammasomes in infectious diseases. Immunol Rev.
277:61–75. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Ye D, Xu Y, Shi Y, Fan M, Lu P, Bai X,
Feng Y, Hu C, Cui K, Tang X, et al: Anti-PANoptosis is involved in
neuroprotective effects of melatonin in acute ocular hypertension
model. J Pineal Res. 73:e128282022. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Du HY, Wang R, Li JL, Luo H, Xie XY, Yan
R, Jian YL and Cai JY: Ligustrazine protects against chronic
hypertensive glaucoma in rats by inhibiting autophagy via the
PI3K-Akt/mTOR pathway. Mol Vis. 27:725–733. 2021.PubMed/NCBI
|
|
140
|
Xu K, Li S, Yang Q, Zhou Z, Fu M, Yang X,
Hao K, Liu Y and Ji H: MicroRNA-145-5p targeting of TRIM2 mediates
the apoptosis of retinal ganglion cells via the PI3K/AKT signaling
pathway in glaucoma. J Gene Med. 23:e33782021. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Li R, Jin Y, Li Q, Sun X, Zhu H and Cui H:
MiR-93-5p targeting PTEN regulates the NMDA-induced autophagy of
retinal ganglion cells via AKT/mTOR pathway in glaucoma. Biomed
Pharmacother. 100:1–7. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Tatton WG, Chalmers-Redman RM, Sud A,
Podos SM and Mittag TW: Maintaining mitochondrial membrane
impermeability. An opportunity for new therapy in glaucoma? Surv
Ophthalmol. 45 (Suppl 3):S277–S283. S295–S296. 2001.PubMed/NCBI
|
|
143
|
Miano M, Madeo A, Cappelli E, Lanza F,
Lanza T, Stroppiano M, Terranova P, Venè R, Bleesing JJH and Di
Rocco M: Defective FAS-mediated apoptosis and immune dysregulation
in gaucher disease. J Allergy Clin Immunol Pract. 8:3535–3542.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Li-Weber M and Krammer PH: Function and
regulation of the CD95 (APO-1/Fas) ligand in the immune system.
Semin Immunol. 15:145–157. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Levoin N, Jean M and Legembre P: CD95
structure, aggregation and cell signaling. Front Cell Dev Biol.
8:3142020. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Guégan JP and Legembre P: Nonapoptotic
functions of Fas/CD95 in the immune response. FEBS J. 285:809–827.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Krishnan A, Fei F, Jones A, Busto P,
Marshak-Rothstein A, Ksander BR and Gregory-Ksander M:
Overexpression of soluble fas ligand following adeno-associated
virus gene therapy prevents retinal ganglion cell death in chronic
and acute murine models of glaucoma. J Immunol. 197:4626–4638.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Gregory-Ksander M and Marshak-Rothstein A:
The FasLane to ocular pathology-metalloproteinase cleavage of
membrane-bound FasL determines FasL function. J Leukoc Biol.
110:965–977. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Razeghinejad MR and Kamali-Sarvestani E:
Aqueous humor levels of soluble Fas and Fas-ligand in patients with
primary open angle and pseudoexfoliation glaucoma. Iran J Immunol.
4:215–219. 2007.PubMed/NCBI
|
|
150
|
Gregory MS, Hackett CG, Abernathy EF, Lee
KS, Saff RR, Hohlbaum AM, Moody KS, Hobson MW, Jones A, Kolovou P,
et al: Opposing roles for membrane bound and soluble Fas ligand in
glaucoma-associated retinal ganglion cell death. PLoS One.
6:e176592011. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
O' Reilly LA, Tai L, Lee L, Kruse EA,
Grabow S, Fairlie WD, Haynes NM, Tarlinton DM, Zhang JG, Belz GT,
et al: Membrane-bound Fas ligand only is essential for Fas-induced
apoptosis. Nature. 461:659–663. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Wax MB, Tezel G, Yang J, Peng G, Patil RV,
Agarwal N, Sappington RM and Calkins DJ: Induced autoimmunity to
heat shock proteins elicits glaucomatous loss of retinal ganglion
cell neurons via activated T-cell-derived fas-ligand. J Neurosci.
28:12085–12096. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Besirli CG, Chinskey ND, Zheng QD and
Zacks DN: Inhibition of retinal detachment-induced apoptosis in
photoreceptors by a small peptide inhibitor of the fas receptor.
Invest Ophthalmol Vis Sci. 51:2177–2184. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Aoki K, Kurooka M, Chen JJ, Petryniak J,
Nabel EG and Nabel GJ: Extracellular matrix interacts with soluble
CD95L: Retention and enhancement of cytotoxicity. Nat Immunol.
2:333–337. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
155
|
Bai Y, Shi Z, Zhuo Y, Liu J, Malakhov A,
Ko E, Burgess K, Schaefer H, Esteban PF, Tessarollo L and Saragovi
HU: In glaucoma the upregulated truncated TrkC.T1 receptor isoform
in glia causes increased TNF-alpha production, leading to retinal
ganglion cell death. Invest Ophthalmol Vis Sci. 51:6639–6651. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Aggarwal BB, Gupta SC and Kim JH:
Historical perspectives on tumor necrosis factor and its
superfamily: 25 Years later, a golden journey. Blood. 119:651–665.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Kelker HC, Oppenheim JD, Stone-Wolff D,
Henriksen-DeStefano D, Aggarwal BB, Stevenson HC and Vilcek J:
Characterization of human tumor necrosis factor produced by
peripheral blood monocytes and its separation from lymphotoxin. Int
J Cancer. 36:69–73. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Subedi L, Lee SE, Madiha S, Gaire BP, Jin
M, Yumnam S and Kim SY: Phytochemicals against TNFα-mediated
neuroinflammatory diseases. Int J Mol Sci. 21:7642020. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Pegoretti V, Baron W, Laman JD and Eisel
ULM: Selective modulation of TNF-TNFRs signaling: Insights for
multiple sclerosis treatment. Front Immunol. 9:9252018. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Sivakumar V, Foulds WS, Luu CD, Ling EA
and Kaur C: Retinal ganglion cell death is induced by microglia
derived pro-inflammatory cytokines in the hypoxic neonatal retina.
J Pathol. 224:245–260. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Cueva Vargas JL, Osswald IK, Unsain N,
Aurousseau MR, Barker PA, Bowie D and Di Polo A: Soluble tumor
necrosis factor alpha promotes retinal ganglion cell death in
glaucoma via calcium-permeable AMPA receptor activation. J
Neurosci. 35:12088–12102. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Lee JC, Park CW, Shin MC, Cho JH, Lee HA,
Kim YM, Park JH, Ahn JH, Cho JH, Tae HJ, et al: Tumor necrosis
factor receptor 2 is required for ischemic preconditioning-mediated
neuroprotection in the hippocampus following a subsequent longer
transient cerebral ischemia. Neurochem Int. 118:292–303. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Agarwal R and Agarwal P: Glaucomatous
neurodegeneration: An eye on tumor necrosis factor-alpha. Indian J
Ophthalmol. 60:255–261. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Levkovitch-Verbin H, Waserzoog Y, Vander
S, Makarovsky D and Piven I: Minocycline upregulates pro-survival
genes and downregulates pro-apoptotic genes in experimental
glaucoma. Graefes Arch Clin Exp Ophthalmol. 252:761–772. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Taurone S, Ripandelli G, Pacella E,
Bianchi E, Plateroti AM, De Vito S, Plateroti P, Grippaudo FR,
Cavallotti C and Artico M: Potential regulatory molecules in the
human trabecular meshwork of patients with glaucoma:
Immunohistochemical profile of a number of inflammatory cytokines.
Mol Med Rep. 11:1384–1390. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Choi JA, Maddala R, Karnam S, Skiba NP,
Vann R, Challa P and Rao PV: Role of vasorin, an anti-apoptotic,
anti-TGF-β and hypoxia-induced glycoprotein in the trabecular
meshwork cells and glaucoma. J Cell Mol Med. 26:2063–2075. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Morgan MJ and Liu ZG: Reactive oxygen
species in TNFalpha-induced signaling and cell death. Mol Cells.
30:1–12. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Madeira MH, Elvas F, Boia R, Gonçalves FQ,
Cunha RA, Ambrósio AF and Santiago AR: Adenosine A2AR blockade
prevents neuroinflammation-induced death of retinal ganglion cells
caused by elevated pressure. J Neuroinflammation. 12:1152015.
View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Bozkurt B, Mesci L, Irkec M, Ozdag BB,
Sanal O, Arslan U, Ersoy F and Tezcan I: Association of tumour
necrosis factor-alpha-308 G/A polymorphism with primary open-angle
glaucoma. Clin Exp Ophthalmol. 40:e156–e162. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Lin HJ, Tsai FJ, Chen WC, Shi YR, Hsu Y
and Tsai SW: Association of tumour necrosis factor alpha-308 gene
polymorphism with primary open-angle glaucoma in Chinese. Eye
(Lond). 17:31–34. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Singh A, Ni J and Aggarwal BB: Death
domain receptors and their role in cell demise. J Interferon
Cytokine Res. 18:439–450. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Lavrik I, Golks A and Krammer PH: Death
receptor signaling. J Cell Sci. 118:265–267. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Zalewska R, Zalewski B, Reszec J, Mariak
Z, Zimnoch L and Proniewska-Skretek E: The expressions of Fas and
caspase-3 in human glaucomatous optic nerve axons. Med Sci Monit.
14:BR274–BR278. 2008.PubMed/NCBI
|
|
174
|
Pawar M, Busov B, Chandrasekhar A, Yao J,
Zacks DN and Besirli CG: FAS apoptotic inhibitory molecule 2 is a
stress-induced intrinsic neuroprotective factor in the retina. Cell
Death Differ. 24:1799–1810. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Tezel G: TNF-alpha signaling in
glaucomatous neurodegeneration. Prog Brain Res. 173:409–421. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Yan X, Tezel G, Wax MB and Edward DP:
Matrix metalloproteinases and tumor necrosis factor alpha in
glaucomatous optic nerve head. Arch Ophthalmol. 118:666–673. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Yuan L and Neufeld AH: Tumor necrosis
factor-alpha: A potentially neurodestructive cytokine produced by
glia in the human glaucomatous optic nerve head. Glia. 32:42–50.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Tezel G, Li LY, Patil RV and Wax MB:
TNF-alpha and TNF-alpha receptor-1 in the retina of normal and
glaucomatous eyes. Invest Ophthalmol Vis Sci. 42:1787–1794.
2001.PubMed/NCBI
|
|
179
|
Cheng S, Wang HN, Xu LJ, Li F, Miao Y, Lei
B, Sun X and Wang Z: Soluble tumor necrosis factor-alpha-induced
hyperexcitability contributes to retinal ganglion cell apoptosis by
enhancing Nav1.6 in experimental glaucoma. J Neuroinflammation.
18:1822021. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Nakazawa T, Nakazawa C, Matsubara A, Noda
K, Hisatomi T, She H, Michaud N, Hafezi-Moghadam A, Miller JW and
Benowitz LI: Tumor necrosis factor-alpha mediates oligodendrocyte
death and delayed retinal ganglion cell loss in a mouse model of
glaucoma. J Neurosci. 26:12633–12641. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Hänninen VA, Pantcheva MB, Freeman EE,
Poulin NR and Grosskreutz CL: Activation of caspase 9 in a rat
model of experimental glaucoma. Curr Eye Res. 25:389–395. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Chi W, Li F, Chen H, Wang Y, Zhu Y, Yang
X, Zhu J, Wu F, Ouyang H, Ge J, et al: Caspase-8 promotes
NLRP1/NLRP3 inflammasome activation and IL-1β production in acute
glaucoma. Proc Natl Acad Sci USA. 111:11181–11186. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Yang X, Zeng Q and Tezel G: Regulation of
distinct caspase-8 functions in retinal ganglion cells and
astroglia in experimental glaucoma. Neurobiol Dis. 150:1052582021.
View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Choudhury S, Liu Y, Clark AF and Pang IH:
Caspase-7: A critical mediator of optic nerve injury-induced
retinal ganglion cell death. Mol Neurodegener. 10:402015.
View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Vigneswara V, Akpan N, Berry M, Logan A,
Troy CM and Ahmed Z: Combined suppression of CASP2 and CASP6
protects retinal ganglion cells from apoptosis and promotes axon
regeneration through CNTF-mediated JAK/STAT signalling. Brain.
137:1656–1675. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Seong H, Ryu J, Yoo WS, Kim SJ, Han YS,
Park JM, Kang SS and Seo SW: Resveratrol ameliorates retinal
ischemia/reperfusion injury in C57BL/6J mice via downregulation of
caspase-3. Curr Eye Res. 42:1650–1658. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Thomas CN, Berry M, Logan A, Blanch RJ and
Ahmed Z: Caspases in retinal ganglion cell death and axon
regeneration. Cell Death Discov. 3:170322017. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Ngan BY, Chen-Levy Z, Weiss LM, Warnke RA
and Cleary ML: Expression in non-Hodgkin's lymphoma of the bcl-2
protein associated with the t(14;18) chromosomal translocation. N
Engl J Med. 318:1638–1644. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Maes ME, Schlamp CL and Nickells RW: BAX
to basics: How the BCL2 gene family controls the death of retinal
ganglion cells. Prog Retin Eye Res. 57:1–25. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Singh R, Letai A and Sarosiek K:
Regulation of apoptosis in health and disease: The balancing act of
BCL-2 family proteins. Nat Rev Mol Cell Biol. 20:175–193. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Cottet S and Schorderet DF: Triggering of
Bcl-2-related pathway is associated with apoptosis of
photoreceptors in Rpe65-/- mouse model of Leber's congenital
amaurosis. Apoptosis. 13:329–342. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Zalewska R, Reszeć J, Mariak Z and
Sulkowski S: The expression of Bcl-2, Bcl-xl, Bak and Bax proteins
in axons of the optic nerve in closed-angle glaucoma. Klin Oczna.
106 (1–2 Suppl):S155–S157. 2004.(In Polish). PubMed/NCBI
|
|
193
|
Takahashi A, Masuda A, Sun M, Centonze VE
and Herman B: Oxidative stress-induced apoptosis is associated with
alterations in mitochondrial caspase activity and Bcl-2-dependent
alterations in mitochondrial pH (pHm). Brain Res Bull. 62:497–504.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Tatton WG, Chalmers-Redman RM and Tatton
NA: Apoptosis and anti-apoptosis signalling in glaucomatous
retinopathy. Eur J Ophthalmol. 11 (Suppl 2):S12–S22.
2001.PubMed/NCBI
|
|
195
|
Ye D, Shi Y, Xu Y and Huang J: PACAP
attenuates optic nerve crush-induced retinal ganglion cell
apoptosis via activation of the CREB-Bcl-2 pathway. J Mol Neurosci.
68:475–484. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
196
|
González-García M, García I, Ding L,
O'Shea S, Boise LH, Thompson CB and Núñez G: bcl-x is expressed in
embryonic and postnatal neural tissues and functions to prevent
neuronal cell death. Proc Natl Acad Sci USA. 92:4304–4308. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Liu XH, Collier RJ and Youle RJ:
Inhibition of axotomy-induced neuronal apoptosis by extracellular
delivery of a Bcl-XL fusion protein. J Biol Chem. 276:46326–46332.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Malik JMI, Shevtsova Z, Bähr M and Kügler
S: Long-term in vivo inhibition of CNS neurodegeneration by Bcl-XL
gene transfer. Mol Ther. 11:373–381. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
199
|
Donahue RJ, Fehrman RL, Gustafson JR and
Nickells RW: BCLX(L) gene therapy moderates neuropathology in the
DBA/2J mouse model of inherited glaucoma. Cell Death Dis.
12:7812021. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Näpänkangas U, Lindqvist N, Lindholm D and
Hallböök F: Rat retinal ganglion cells upregulate the pro-apoptotic
BH3-only protein Bim after optic nerve transection. Brain research.
Brain Res Mol Brain Res. 120:30–37. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Donahue RJ, Maes ME, Grosser JA and
Nickells RW: BAX-depleted retinal ganglion cells survive and become
quiescent following optic nerve damage. Mol Neurobiol.
57:1070–1084. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Wei Y, Fan T and Yu M: Inhibitor of
apoptosis proteins and apoptosis. Acta Biochim Biophys Sin
(Shanghai). 40:278–288. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
203
|
Levkovitch-Verbin H, Dardik R, Vander S,
Nisgav Y, Kalev-Landoy M and Melamed S: Experimental glaucoma and
optic nerve transection induce simultaneous upregulation of
proapoptotic and prosurvival genes. Invest Ophthalmol Vis Sci.
47:2491–2497. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
204
|
Kisiswa L, Albon J, Morgan JE and Wride
MA: Cellular inhibitor of apoptosis (cIAP1) is down-regulated
during retinal ganglion cell (RGC) maturation. Exp Eye Res.
91:739–747. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
205
|
Levkovitch-Verbin H, Vander S, Makarovsky
D and Lavinsky F: Increase in retinal ganglion cells'
susceptibility to elevated intraocular pressure and impairment of
their endogenous neuroprotective mechanism by age. Mol Vis.
19:2011–2022. 2013.PubMed/NCBI
|
|
206
|
Ayub H, Micheal S, Akhtar F, Khan MI,
Bashir S, Waheed NK, Ali M, Schoenmaker-Koller FE, Shafique S,
Qamar R and Hollander AI: Association of a polymorphism in the
BIRC6 gene with pseudoexfoliative glaucoma. PLoS One.
9:e1050232014. View Article : Google Scholar : PubMed/NCBI
|
|
207
|
Carbone MA, Chen Y, Hughes GA, Weinreb RN,
Zabriskie NA, Zhang K and Anholt RR: Genes of the unfolded protein
response pathway harbor risk alleles for primary open angle
glaucoma. PLoS One. 6:e206492011. View Article : Google Scholar : PubMed/NCBI
|
|
208
|
Kernt M, Neubauer AS, Eibl KH, Wolf A,
Ulbig MW, Kampik A and Hirneiss C: Minocycline is cytoprotective in
human trabecular meshwork cells and optic nerve head astrocytes by
increasing expression of XIAP, survivin, and Bcl-2. Clin
Ophthalmol. 4:591–604. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
209
|
Liu L and Yang X, Zhang J, Jiang W, Hou T,
Zong Y, Bai H, Yang K and Yang X: Long non-coding RNA SNHG11
regulates the Wnt/β-catenin signaling pathway through rho/ROCK in
trabecular meshwork cells. FASEB J. 37:e228732023. View Article : Google Scholar : PubMed/NCBI
|
|
210
|
Levkovitch-Verbin H, Makarovsky D and
Vander S: Comparison between axonal and retinal ganglion cell gene
expression in various optic nerve injuries including glaucoma. Mol
Vis. 19:2526–2541. 2013.PubMed/NCBI
|
|
211
|
Murray-Zmijewski F, Lane DP and Bourdon
JC: p53/p63/p73 isoforms: an orchestra of isoforms to harmonise
cell differentiation and response to stress. Cell Death Differ.
13:962–972. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
212
|
Lane DP, Lu X, Hupp T and Hall PA: The
role of the p53 protein in the apoptotic response. Philos Trans R
Soc Lond B Biol Sci. 345:277–280. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
213
|
Peng Q, Lao X, Chen Z, Lai H, Deng Y, Wang
J, Mo C, Sui J, Wu J, Zhai L, et al: TP53 and MDM2 gene
polymorphisms, gene-gene interaction, and hepatocellular carcinoma
risk: evidence from an updated meta-analysis. PLoS One.
8:e827732013. View Article : Google Scholar : PubMed/NCBI
|
|
214
|
Lin HJ, Chen WC, Tsai FJ and Tsai SW:
Distributions of p53 codon 72 polymorphism in primary open angle
glaucoma. Br J Ophthalmol. 86:767–770. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
215
|
Chipuk JE, Kuwana T, Bouchier-Hayes L,
Droin NM, Newmeyer DD, Schuler M and Green DR: Direct activation of
Bax by p53 mediates mitochondrial membrane permeabilization and
apoptosis. Science. 303:1010–1014. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
216
|
Acharya M, Mitra S, Mukhopadhyay A, Khan
M, Roychoudhury S and Ray K: Distribution of p53 codon 72
polymorphism in Indian primary open angle glaucoma patients. Mol
Vis. 8:367–371. 2002.PubMed/NCBI
|
|
217
|
Ara S, Lee PS, Hansen MF and Saya H: Codon
72 polymorphism of the TP53 gene. Nucleic Acids Res. 18:49611990.
View Article : Google Scholar : PubMed/NCBI
|
|
218
|
Fan BJ, Liu K, Wang DY, Tham CC, Tam PO,
Lam DS and Pang CP: Association of polymorphisms of tumor necrosis
factor and tumor protein p53 with primary open-angle glaucoma.
Invest Ophthalmol Vis Sci. 51:4110–4116. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
219
|
Gupta S, Chatterjee S, Chandra A, Maurya
OPS, Mishra RN, Mukherjee A and Mutsuddi M: TP53 codon 72
polymorphism and the risk of glaucoma in a north Indian cohort: A
genetic association study. Ophthalmic Genet. 39:228–235. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
220
|
Guo Y, Zhang H, Chen X, Yang X, Cheng W
and Zhao K: Association of TP53 polymorphisms with primary
open-angle glaucoma: A meta-analysis. Invest Ophthalmol Vis Sci.
53:3756–3763. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
221
|
Gohari M, Neámatzadeh H, Jafari MA,
Mazaheri M, Zare-Shehneh M and Abbasi-Shavazi E: Association
between the p53 codon 72 polymorphism and primary open-angle
glaucoma risk: Meta-analysis based on 11 case-control studies.
Indian J Ophthalmol. 64:756–761. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
222
|
Blanco-Marchite C, Sánchez-Sánchez F,
López-Garrido MP, Iñigez-de-Onzoño M, López-Martínez F,
López-Sánchez E, Alvarez L, Rodríguez-Calvo PP, Méndez-Hernández C,
Fernández-Vega L, et al: WDR36 and P53 gene variants and
susceptibility to primary open-angle glaucoma: analysis of
gene-gene interactions. Invest Ophthalmol Vis Sci. 52:8467–8478.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
223
|
Neamatzadeh H, Soleimanizad R, Atefi A,
Zare-Shehneh M, Gharibi S, Shekari A and Rahimzadeh AB: Association
between p53 codon 72 (Arg72Pro) polymorphism and primary open-angle
glaucoma in Iranian patients. Iran Biomed J. 19:51–56.
2015.PubMed/NCBI
|
|
224
|
Wiggs JL, Hewitt AW, Fan BJ, Wang DY,
Figueiredo Sena DR, O'Brien C, Realini A, Craig JE, Dimasi DP,
Mackey DA, et al: The p53 codon 72 PRO/PRO genotype may be
associated with initial central visual field defects in caucasians
with primary open angle glaucoma. PLoS One. 7:e456132012.
View Article : Google Scholar : PubMed/NCBI
|
|
225
|
Jeong BS, Hu W, Belyi V, Rabadan R and
Levine AJ: Differential levels of transcription of p53-regulated
genes by the arginine/proline polymorphism: p53 with arginine at
codon 72 favors apoptosis. FASEB J. 24:1347–1353. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
226
|
Dimasi DP, Hewitt AW, Green CM, Mackey DA
and Craig JE: Lack of association of p53 polymorphisms and
haplotypes in high and normal tension open angle glaucoma. J Med
Genet. 42:e552005. View Article : Google Scholar : PubMed/NCBI
|
|
227
|
Silva RE, Arruda JT, Rodrigues FW and
Moura KKVO: Primary open angle glaucoma was not found to be
associated with p53 codon 72 polymorphism in a Brazilian cohort.
Genet Mol Res. 8:268–272. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
228
|
Mabuchi F, Sakurada Y, Kashiwagi K,
Yamagata Z, Iijima H and Tsukahara S: Lack of association between
p53 gene polymorphisms and primary open angle glaucoma in the
Japanese population. Mol Vis. 15:1045–1049. 2009.PubMed/NCBI
|
|
229
|
Saglar E, Yucel D, Bozkurt B, Ozgul RK,
Irkec M and Ogus A: Association of polymorphisms in APOE, p53, and
p21 with primary open-angle glaucoma in Turkish patients. Mol Vis.
15:1270–1276. 2009.PubMed/NCBI
|
|
230
|
Chen SD, Wang L and Zhang XL:
Neuroprotection in glaucoma: Present and future. Chin Med J (Engl).
126:1567–1577. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
231
|
Tahzib NG, Ransom NL, Reitsamer HA and
McKinnon SJ: Alpha-fodrin is cleaved by caspase-3 in a chronic
ocular hypertensive (COH) rat model of glaucoma. Brain Res Bull.
62:491–495. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
232
|
Vigneswara V, Berry M, Logan A and Ahmed
Z: Pharmacological inhibition of caspase-2 protects axotomised
retinal ganglion cells from apoptosis in adult rats. PLoS One.
7:e534732012. View Article : Google Scholar : PubMed/NCBI
|
|
233
|
Monnier PP, D'Onofrio PM, Magharious M,
Hollander AC, Tassew N, Szydlowska K, Tymianski M and Koeberle PD:
Involvement of caspase-6 and caspase-8 in neuronal apoptosis and
the regenerative failure of injured retinal ganglion cells. J
Neurosci. 31:10494–10505. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
234
|
Liu Y, Yan H, Chen S and Sabel BA:
Caspase-3 inhibitor Z-DEVD-FMK enhances retinal ganglion cell
survival and vision restoration after rabbit traumatic optic nerve
injury. Restor Neurol Neurosci. 33:205–220. 2015.PubMed/NCBI
|
|
235
|
Sánchez-Migallón MC, Valiente-Soriano FJ,
Nadal-Nicolás FM, Vidal-Sanz M and Agudo-Barriuso M: Apoptotic
retinal ganglion cell death after optic nerve transection or crush
in mice: Delayed RGC loss with BDNF or a caspase 3 inhibitor.
Invest Ophthalmol Vis Sci. 57:81–93. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
236
|
Nakazawa T, Tamai M and Mori N:
Brain-derived neurotrophic factor prevents axotomized retinal
ganglion cell death through MAPK and PI3K signaling pathways.
Invest Ophthalmol Vis Sci. 43:3319–3326. 2002.PubMed/NCBI
|
|
237
|
Tawfik M, Zhang X, Grigartzik L,
Heiduschka P, Hintz W, Henrich-Noack P, van Wachem B and Sabel BA:
Gene therapy with caspase-3 small interfering RNA-nanoparticles is
neuroprotective after optic nerve damage. Neural Regen Res.
16:2534–2541. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
238
|
Ahmed Z, Kalinski H, Berry M, Almasieh M,
Ashush H, Slager N, Brafman A, Spivak I, Prasad N, Mett I, et al:
Ocular neuroprotection by siRNA targeting caspase-2. Cell Death
Dis. 2:e1732011. View Article : Google Scholar : PubMed/NCBI
|
|
239
|
Elewa HF, Hilali H, Hess DC, Machado LS
and Fagan SC: Minocycline for short-term neuroprotection.
Pharmacotherapy. 26:515–521. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
240
|
Bosco A, Inman DM, Steele MR, Wu G, Soto
I, Marsh-Armstrong N, Hubbard WC, Calkins DJ, Horner PJ and Vetter
ML: Reduced retina microglial activation and improved optic nerve
integrity with minocycline treatment in the DBA/2J mouse model of
glaucoma. Invest Ophthalmol Vis Sci. 49:1437–1446. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
241
|
Huang W, Gao F, Hu F, Huang J, Wang M, Xu
P, Zhang R, Chen J, Sun X, Zhang S and Wu J: Asiatic acid prevents
retinal ganglion cell apoptosis in a rat model of glaucoma. Front
Neurosci. 12:4892018. View Article : Google Scholar : PubMed/NCBI
|
|
242
|
Hu X, Zhuang D, Zhang R, Sun X, Lu Q and
Dai Y: The small molecule inhibitor PR-619 protects retinal
ganglion cells against glutamate excitotoxicity. Neuroreport.
31:1134–1141. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
243
|
Wu X, Pang Y, Zhang Z, Li X, Wang C, Lei
Y, Li A, Yu L and Ye J: Mitochondria-targeted antioxidant peptide
SS-31 mediates neuroprotection in a rat experimental glaucoma
model. Acta Biochim Biophys Sin (Shanghai). 51:411–421. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
244
|
Shi Y, Ye D, Huang R, Xu Y, Lu P, Chen H
and Huang J: Down syndrome critical region 1 reduces oxidative
stress-induced retinal ganglion cells apoptosis via CREB-Bcl-2
pathway. Invest Ophthalmol Vis Sci. 61:232020. View Article : Google Scholar : PubMed/NCBI
|
|
245
|
Dai Y, Lawrence TS and Xu L: Overcoming
cancer therapy resistance by targeting inhibitors of apoptosis
proteins and nuclear factor-kappa B. Am J Transl Res. 1:1–15.
2009.PubMed/NCBI
|
|
246
|
McKinnon SJ, Lehman DM, Tahzib NG, Ransom
NL, Reitsamer HA, Liston P, LaCasse E, Li Q, Korneluk RG and
Hauswirth WW: Baculoviral IAP repeat-containing-4 protects optic
nerve axons in a rat glaucoma model. Mol Ther. 5:780–787. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
247
|
Visuvanathan S, Baker AN, Lagali PS,
Coupland SG, Miller G, Hauswirth WW and Tsilfidis C: XIAP gene
therapy effects on retinal ganglion cell structure and function in
a mouse model of glaucoma. Gene Ther. 29:147–156. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
248
|
Wang XC, Wang T, Zhang Y, Wang LL, Zhao RY
and Tan W: Tacrolimus inhibits proliferation and induces apoptosis
by decreasing survivin in scar fibroblasts after glaucoma surgery.
Eur Rev Med Pharmacol Sci. 22:2934–2940. 2018.PubMed/NCBI
|
|
249
|
Lee J, Choi JH and Joo CK: TGF-β1
regulates cell fate during epithelial-mesenchymal transition by
upregulating survivin. Cell Death Dis. 4:e7142013. View Article : Google Scholar : PubMed/NCBI
|
|
250
|
Honjo M and Tanihara H: Impact of the
clinical use of ROCK inhibitor on the pathogenesis and treatment of
glaucoma. Jpn J Ophthalmol. 62:109–126. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
251
|
Wang J, Wang H and Dang Y: Rho-kinase
inhibitors as emerging targets for glaucoma therapy. Ophthalmol
Ther. 12:2943–2957. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
252
|
Chen W and Yang X, Fang J, Zhang Y, Zhu W
and Yang X: Rho-associated protein kinase inhibitor treatment
promotes proliferation and phagocytosis in trabecular meshwork
cells. Front Pharmacol. 11:3022020. View Article : Google Scholar : PubMed/NCBI
|
|
253
|
Garnock-Jones KP: Ripasudil: First global
approval. Drugs. 74:2211–2215. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
254
|
Sturdivant JM, Royalty SM, Lin CW, Moore
LA, Yingling JD, Laethem CL, Sherman B, Heintzelman GR, Kopczynski
CC and de Long MA: Discovery of the ROCK inhibitor netarsudil for
the treatment of open-angle glaucoma. Bioorg Med Chem Lett.
26:2475–2480. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
255
|
Tanna AP and Johnson M: Rho kinase
inhibitors as a novel treatment for glaucoma and ocular
hypertension. Ophthalmology. 125:1741–1756. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
256
|
Testa V, Ferro Desideri L, Della Giustina
P, Traverso CE and Iester M: An update on ripasudil for the
treatment of glaucoma and ocular hypertension. Drugs Today (Barc).
56:599–608. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
257
|
Li DW, Liu JP, Schmid PC, Schlosser R,
Feng H, Liu WB, Yan Q, Gong L, Sun SM, Deng M and Liu Y: Protein
serine/threonine phosphatase-1 dephosphorylates p53 at Ser-15 and
Ser-37 to modulate its transcriptional and apoptotic activities.
Oncogene. 25:3006–3022. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
258
|
Yang Z, Ge J, Yin W, Shen H, Liu H and Guo
Y: The expression of p53, MDM2 and Ref1 gene in cultured retina
neurons of SD rats treated with vitamin B1 and/or elevated
pressure. Yan Ke Xue Bao. 20:259–263. 2004.(In Chinese). PubMed/NCBI
|
|
259
|
Johnson KT, Rödicker F, Heise K, Heinz C,
Steuhl KP, Pützer BM and Hudde T: Adenoviral p53 gene transfer
inhibits human Tenon's capsule fibroblast proliferation. Br J
Ophthalmol. 89:508–512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
260
|
Husain S, Ahmad A, Singh S, Peterseim C,
Abdul Y and Nutaitis MJ: PI3K/Akt pathway: A role in δ-opioid
receptor-mediated RGC neuroprotection. Invest Ophthalmol Vis Sci.
58:6489–6499. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
261
|
Zhao N, Shi J, Xu H, Luo Q, Li Q and Liu
M: Baicalin suppresses glaucoma pathogenesis by regulating the
PI3K/AKT signaling in vitro and in vivo. Bioengineered.
12:10187–10198. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
262
|
Xi X, Chen Q, Ma J, Wang X, Xia Y, Wen X,
Cai B and Li Y: Acteoside protects retinal ganglion cells from
experimental glaucoma by activating the PI3K/AKT signaling pathway
via caveolin 1 upregulation. Ann Transl Med. 10:3122022. View Article : Google Scholar : PubMed/NCBI
|
|
263
|
Nie XG, Fan DS, Huang YX, He YY, Dong BL
and Gao F: Downregulation of microRNA-149 in retinal ganglion cells
suppresses apoptosis through activation of the PI3K/Akt signaling
pathway in mice with glaucoma. Am J Physiol Cell Physiol.
315:C839–C849. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
264
|
Perkins TW, Faha B, Ni M, Kiland JA,
Poulsen GL, Antelman D, Atencio I, Shinoda J, Sinha D, Brumback L,
et al: Adenovirus-mediated gene therapy using human p21WAF-1/Cip-1
to prevent wound healing in a rabbit model of glaucoma filtration
surgery. Arch Ophthalmol. 120:941–949. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
265
|
Heatley G, Kiland J, Faha B, Seeman J,
Schlamp CL, Dawson DG, Gleiser J, Maneval D, Kaufman PL and
Nickells RW: Gene therapy using p21WAF-1/Cip-1 to modulate wound
healing after glaucoma trabeculectomy surgery in a primate model of
ocular hypertension. Gene Ther. 11:949–955. 2004. View Article : Google Scholar : PubMed/NCBI
|
